Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health
|
Federally funded bilateral health agreements on National Strategy for Drugs for Rare Disease
|
Policies or Program
|
Health
|
Issues related to pharmacare program and the overall strategy for Drugs for Rare Disease and access to orphan drugs.
|
Policies or Program
|
Address:
1004 Middlegate Road Suite 5000 L4Y 1M4
Mississauga, ON L4Y 1M4
Canada
Telephone number:
844-922-0605
Kathleen Whelan, Country lead, International Government Affairs & Policy
Alexion Pharma Canada Corp. is not a coalition.
The activities of Alexion Pharma Canada Corp. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Alexion Pharma Canada Corp. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Danielle Flieler | No public offices held
Firm: Santis Health / Santis Health